Ionis Pharmaceuticals (IONS) PT Raised to $115 at Barclays

April 30, 2026 6:01 AM

Barclays analyst Eliana Merle raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $115.00 (from $106.00) while maintaining a Overweight rating.

No results found